Successful management of a neonate with OTC deficiency presenting with hyperammonemia and severe cardiac dysfunction with extracorporeal membrane oxygenation support and continuous renal replacement therapy
Abstract Ornithine transcarbamylase (OTC) deficiency is an X‐linked urea cycle disorder which—in severe form—results in rapid accumulation of ammonia and glutamine with subsequent irreversible brain injury. We present a case of severe left ventricular dysfunction with hyperammonemic crisis caused by...
Main Authors: | Adrian C. Mattke, Fumiaki Shikata, James McGill, Rob Justo, Prem Venugopal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | JIMD Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/jmd2.12135 |
Similar Items
-
Restoring ornithine transcarbamylase (OTC) activity in an OTC‐deficient mouse model using LUNAR‐OTC mRNA
by: Hailong Yu, et al.
Published: (2022-06-01) -
Extracorporeal Membrane Oxygenation (ECMO)—A Lifesaving Technology. Review and Single-center
by: Maged Makhoul, et al.
Published: (2019-04-01) -
Optimizing renal replacement therapy for patients who need extracorporeal membrane oxygenation: cross-talk between two organ support machines
by: Kianoush Kashani, et al.
Published: (2019-11-01) -
Over-the -counter medicines (OTC), how to avoid causing health problems?
by: Théophile eGodfraind
Published: (2012-10-01) -
Hyperammonemic coma in a patient with late-onset OTC deficiency
by: V. D’Onofrio, et al.
Published: (2014-06-01)